CompletedPhase 2NCT03663855
Effect of Increasing Doses of Tiopronin on Cystine Capacity in Patients With Cystinuria
Studying Cystinuria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- NYU Langone Health
- Principal Investigator
- David Goldfarb, MD, M.DNYU Langone Health
- Intervention
- Tiopronin(drug)
- Enrollment
- 10 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2018 – 2019
Study locations (1)
- New York University School of Medicine, New York, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03663855 on ClinicalTrials.govOther trials for Cystinuria
Additional recruiting or active studies for the same condition.